Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menachem Laufer

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Harefuah|March 26, 2023
[PARADIGM SHIFTS IN DIAGNOSIS AND MANAGEMENT OF LOCALIZED PROSTATE CANCER IN 2022]Menachem Laufer
Harefuah|January 31, 2024
[PHYTOTHERAPY AND NATURAL AGENTS IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH)]Menachem Laufer, Shir Shoenfeld
Clinical Imaging|July 13, 2013
Hematospermia--the added value of transrectal ultrasound to clinical evaluation: is transrectal ultrasound necessary for evaluation of hematospermia?Gil Raviv, Menachem Laufer, Haifler Miki
Comprehensive Psychiatry|June 25, 2014
Risk of prostate cancer in patients with schizophreniaGil Raviv, Menachem Laufer, Yehuda Baruch, et al.
Urology|October 20, 2004
Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancerOfer Nativ, Eilata Dalal, Menachem Laufer, et al.
European Urology Open Science|September 11, 2023
Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 PatientsMenachem Laufer, Maxim Perelman, Michal Sarfaty, et al.
Harefuah|October 13, 2005
[The laparoscopic approach to renal tumors outcome of 121 laparoscopic radical and partial nephrectomy procedures]Andrei Nadu, Menachem Laufer, Harry Winkler, et al.
Cancers|January 11, 2024
Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is Associated with Decreased Survival of Bladder Cancer Patients and Survivors-A Retrospective Data Analysis of 3075 PatientsMenachem Laufer, Maxim Perelman, Gad Segal, et al.
Harefuah|May 6, 2014
[InoPro trial: collaboration between urologists and primary care physicians in the treatment of osteoporosis in prostate cancer patients]Menachem Laufer, Thomas Keller, Vladimir Gershman, et al.
Journal of Clinical Medicine|October 16, 2024
Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 PatientsMenachem Laufer, Michal Sarfaty, Eyal Jacobi, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Harefuah|March 26, 2023
[PARADIGM SHIFTS IN DIAGNOSIS AND MANAGEMENT OF LOCALIZED PROSTATE CANCER IN 2022]Menachem Laufer
Harefuah|January 31, 2024
[PHYTOTHERAPY AND NATURAL AGENTS IN SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA (BPH)]Menachem Laufer, Shir Shoenfeld
Clinical Imaging|July 13, 2013
Hematospermia--the added value of transrectal ultrasound to clinical evaluation: is transrectal ultrasound necessary for evaluation of hematospermia?Gil Raviv, Menachem Laufer, Haifler Miki
Comprehensive Psychiatry|June 25, 2014
Risk of prostate cancer in patients with schizophreniaGil Raviv, Menachem Laufer, Yehuda Baruch, et al.
Urology|October 20, 2004
Antineoplastic effect of gemcitabine in an animal model of superficial bladder cancerOfer Nativ, Eilata Dalal, Menachem Laufer, et al.
European Urology Open Science|September 11, 2023
Low Alanine Aminotransferase, as a Marker of Sarcopenia and Frailty, Is Associated with Shorter Survival Among Prostate Cancer Patients and Survivors. A Retrospective Cohort Analysis of 4064 PatientsMenachem Laufer, Maxim Perelman, Michal Sarfaty, et al.
Harefuah|October 13, 2005
[The laparoscopic approach to renal tumors outcome of 121 laparoscopic radical and partial nephrectomy procedures]Andrei Nadu, Menachem Laufer, Harry Winkler, et al.
Cancers|January 11, 2024
Low Alanine Aminotransferase as a Marker for Sarcopenia and Frailty, Is Associated with Decreased Survival of Bladder Cancer Patients and Survivors-A Retrospective Data Analysis of 3075 PatientsMenachem Laufer, Maxim Perelman, Gad Segal, et al.
Harefuah|May 6, 2014
[InoPro trial: collaboration between urologists and primary care physicians in the treatment of osteoporosis in prostate cancer patients]Menachem Laufer, Thomas Keller, Vladimir Gershman, et al.
Journal of Clinical Medicine|October 16, 2024
Low Serum Alanine Aminotransferase Blood Activity Is Associated with Shortened Survival of Renal Cell Cancer Patients and Survivors: Retrospective Analysis of 1830 PatientsMenachem Laufer, Michal Sarfaty, Eyal Jacobi, et al.
Pageof 4